MustGrow announces award of RSUs and DSUs

Saskatoon, Saskatchewan–(Newsfile Corp. – September 4, 2024) – MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow“) today announced that the Company’s board of directors has approved the grant of a total of 1,575,398 deferred shares (“DSUs“) and restricted shares (“RSUs“) to certain directors, officers and advisors of the Company, effective September 3, 2024. These awards of DSUs and RSUs are being made pursuant to the Company’s Omnibus Equity Incentive Plan (the “Plan“).

The DSUs are granted when the holder ceases to be a director, officer or employee of the Company or any of its affiliates, as applicable. Upon settlement, each DSU entitles the holder to receive one common share in the capital of the Company or a cash payment equivalent thereto, at the option of the Company.